Custom solid-phase peptide synthesis (SPPS), therapeutic peptide impurities, cyclic stapling, and counter-ion exchange.
As peptide therapeutics and GLP-1/GIP incretin mimetics (Semaglutide, Tirzepatide, Liraglutide) expand globally, pharmaceutical developers require specialized peptide CDMO partners capable of synthesizing difficult sequences, peptide-related impurities, and diastereomeric isomers with audit-proof characterization.
Cleanchem utilizes automated microwave-assisted Solid-Phase Peptide Synthesis (SPPS) and liquid-phase fragment condensation, coupled with preparative reverse-phase HPLC and lyophilization technologies delivering highly pure peptide reference standards and active fragments.
Cleanchem utilizes automated microwave-assisted Solid-Phase Peptide Synthesis (SPPS) and liquid-phase fragment condensation, coupled with preparative reverse-phase HPLC and lyophilization technologies delivering highly pure peptide reference standards and active fragments.
Specialized expertise engineered to resolve complex chemical challenges across target molecules:
Solid-phase peptide synthesis (SPPS) spanning short fragments up to 40+ amino acid residues including disulfide bridge and lactam cyclization.
Synthesis of critical deletion sequences, insertion impurities, D-amino acid diastereomers, and beta-aspartyl rearrangement products.
Complete conversion of crude trifluoroacetate (TFA) salts to physiological Acetate, Hydrochloride, or Sodium counter-ions with sub-0.5% residual TFA.
Controlled freeze-drying cycles yielding fluffy, easily reconstitutable lyophilized powders packed under argon/nitrogen in cleanroom environments.
Transparent, milestone-governed stage gate execution keeping your research program strictly on schedule:
Aggregation prediction analysis, selecting Wang/CTC/Rink Amide resins, and defining orthogonal protecting group strategies (Fmoc/tBu).
Microwave-assisted automated coupling cycles, Kaiser monitoring, cleavage from solid support, and cold ether precipitation.
Multi-step reversed-phase preparative HPLC purification, ion-exchange desalting (TFA to Acetate), and fractions pooling.
Sterile freeze-drying, MALDI-TOF/HRMS sequence mass verification, amino acid analysis (AAA), and ISO 17034 certificate generation.
Our Navi Mumbai and Mahad testing facilities are equipped with qualified, 21 CFR Part 11 compliant hardware:
| Instrument Platform | Technical Specifications | Primary Application |
|---|---|---|
| Automated Microwave Peptide Synthesizer | CSBio & CEM Liberty platforms, automated coupling | High-efficiency solid-phase peptide elongation |
| Waters Preparative HPLC System | Reversed-phase C18 & C4 wide-pore (300Å) columns | High-resolution peptide impurity separation |
| MALDI-TOF / HRMS Mass Spectrometer | Laser desorption ionization with flight tube | Unequivocal peptide molecular weight confirmation |
| Labconco FreeZone Cleanroom Lyophilizer | -84°C cascade refrigeration, nitrogen packaging | Sterile moisture-free lyophilized cake production |
Every project concludes with a complete regulatory package ready for instant DMF/ANDA regulatory submission:
Cleanchem Laboratories successfully participates in Pharmaconex 2026 at the Egypt International Exhibition Center, engaging with pharmaceutical professionals from Egypt and across the region.